Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vactosertib + Durvalumab in Metastatic Gastric Cancer
NCT04893252Phase 2Unknown
- Start
- Jun 2021
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vactosertib in gastric cancer (GC). Status: unknown.
02
Drugs
vactosertib
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT04893252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04893252.